medigraphic.com
ISSN 1560-4381 (Print)

2016, Number 2

<< Back Next >>

Correo Científico Médico 2016; 20 (2)

Biomarkers for dengue severity prediction

León RCC, Betancourt BJA, Nicolau PE, Torres TK

Language: Spanish
References: 41
Page: 305-321
PDF size: 321.71 Kb.


ABSTRACT

From people who acquire dengue, 10 % of them become seriously ill in the first days; it is not yet possible to make an accurate diagnosis only based on clinical and epidemiological diagnosis and either to predict the severity of future behavior of disease. This article is aimed at familiarize health researchers and students with the use of biomarkers for predicting the severity of dengue to integrate interdisciplinary team for making translational research. The effective laboratory method for diagnosing dengue are described and also the clinical prediction based on different biomarkers.


REFERENCES

  1. Tang K, Ooi E. Diagnosis of dengue: an update. Expert Rev Anti Infect Ther. 2012[citado 25 ene 2015]; 10(8):895-907.Disponible en: http://www.tandfonline.com/doi/full/10.1586/eri.12.76#abstract

  2. Estruch Rancaño L, Santín Peña M, Peláez Sánchez O, Molina Águila N, Sierra Pérez D, Muñiz Roque AM. Guía para la asistencia integral a pacientes con dengue. La Habana: Ciencias Médicas; 2012.

  3. Guzmán Tirado MG, Harris E. Dengue. Lancet. 2015[citado 22 feb 2015]; 385(9966):453–465. Disponible en:http://www.sciencedirect.com/science/article/pii/S0140673614605729

  4. Villar LA, Gélvez RM, Rodríguez JA, Salgado D, Parra B, Osorio L, et al. Biomarcadores pronósticos de gravedad del dengue. Biomédica.2013 [citado 25 ene 2016]; 33 (Supl 1):108-116 .Disponible en: http://www.revistabiomedica.org/index.php/biomedica/article/view/733/2169

  5. Kabisch S. Inter- and Transdisciplinarity in Urban- Environmental Research: A Subjective Inventory over Twenty Years. Interdiscipl Scien Revie. 2014[citado 28 abr 2016]; 39(4):392-398. http://www.tandfonline.com/doi/abs/10.1179/0308018814Z.00000000099

  6. Chapman E, Görg C, Spangenberg JH, Tekken V, Burkhard B, Truong DT, Escalada M ,et al. Engaging Local Knowledge in Biodiversity Research: Experiences from Large Inter- and Transdisciplinary Projects. Interdiscipl Scien Revie. 2014[citado 28 abr 2016]; 39(4):323-341. Disponible en: http://www.tandfonline.com/doi/citedby/10.1179/0308018814Z.00000000095

  7. Dankwa Mullan I, Rhee KB, Stoff DM, Pohlhaus JR, Sy FS, Stinson N, et al. Moving Toward Paradigm-Shifting Research in Health Disparities Through Translational, Transformational, and Transdisciplinary Approaches. Am J Public Health. 2010[citado 29 mar 2015]; 100(Supl1):19-24. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837422/

  8. Khoury MJ, Gwinn M , Loannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol.2010 [citado 15 dic 2015]; 172(5):517-524. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927741/pdf/kwq211.pdf

  9. Birkholtz LM, Bornman R, Focke W, Mutero C, de Jager C. Sustainable malaria control: transdisciplinary approaches for translational applications. Malar J. 2012 [citado 25 nov 2015]; 11:431. Disponible en : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548719/

  10. 10 Korb W, Geißler N, Strauß G. Solving challenges in inter- and trans-disciplinary working teams: Lessons from the surgical technology field. Artif Intell Med.2015 [citado 29 oct 2015]; 63(3):209-219.Disponible en: http://www.sciencedirect.com/science/article/pii/S0933365715000020

  11. Memish ZA, Fagbo SF, Assiri AM, Rollin P, Zaki AM, Charrel R, et al. Alkhurma Viral Hemorrhagic Fever Virus. Proposed Guidelines for Detection, Prevention, and Control in Saudi Arabia. PLoS Negl Trop Dis. 2012[citado 7 nov 2015]; 6(7). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409106/

  12. Gan VCH, Leo Y-S. Current epidemiology and clinical practice in arboviral infections – implications on blood supply in South-East Asia. ISBT Sci Ser. 2014 [citado 25 abr 2015]; 9(1):262-267.Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/voxs.12083/abstract

  13. Lahariya C, Goel MK, Kumar A, Puri M, Sodhi A. Emergence of viral hemorrhagic fevers: Is recent outbreak of crimean congo hemorrhagic fever in India andication. J Postgrad Med. 2012[citado 4 abr 2015]; 58(1):39-46.Disponible en: http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2012;volume=58;issue=1;spage=39;epage=46;aulast=Lahariya?

  14. Sam SS, Syed Omar SF, Boon Teong T, Abd Jamil J, AbuBakar S. Review of Dengue Hemorrhagic Fever Fatal Cases Seen Among Adults: A Retrospective Study. PLoS Negl Trop Dis. 2013[citado 25 abr 2015]; 7(5). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642057/

  15. Riffat M, Adnan Shahzad S, Mulazim Hussain B, Asad Aslam K, Fridoon Jawad A .Predictors for Severity of Dengue Infection during Early Days of Infection. Walailak J Sci Tech. 2012 [citado 30 nov 2015]; 9(4):369-374. Disponible en: https://www.researchgate.net/publication/235612777_Predictors_for_Severity_of_Dengue_Infection_during_Early_Days_of_Infection

  16. Guzmán MG, Vázquez S. Apuntes sobre el diagnóstico de laboratorio del virus dengue. Rev Cubana Med Trop. 2002 [citado 16 nov 2015]; 54(3):180-188. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0375-07602002000300003&script=sci_arttext

  17. OMS. Dengue: Guías para el diagnóstico, tratamiento, prevención y

  18. Control. La Paz. Bolivia; OMS. 2009[citado 15 nov 2015]. Disponible en: http://apps.who.int/iris/bitstream/10665/44504/1/9789995479213_spa.pdf

  19. Ho TS, Wang SM, Lin YS, Liu CC. Clinical and laboratory predictive markers for acute dengue infection. J Biomed Sci. 2013 [citado 8 dic 2015]; 20(1):75.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015130/

  20. Peña E V, Rodríguez Porto A L. Fiebres hemorrágicas y virales. Actualización, diagnóstico y tratamiento. La Habana. ECIMED; 2010.

  21. Limonta Velázquez DJ. Marcadores de apoptosis en plasma y tejidos: probables implicaciones en la fisiopatología del dengue [Tesis]. La Habana: Instituto de Medicina Tropical Pedro Kourí; 2013.135p.Disponible en: http://tesis.repo.sld.cu/738/1/TESIS_completa_DrC_Daniel_Limonta_7nov2013.pdf

  22. Real R, Rojas G, Correa D, Barrios MA, Aldama F, Pinchi L, et al. Manifestaciones sistémicas del dengue. Rev Nac (Itauguá). 2013 [citado 18 dic 2015]; 5(2):8-16.Disponible en: http://scielo.iics.una.py/pdf/hn/v5n2/v5n2a02.pdf

  23. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis.2007 [citado 18 dic 2015]; 30(5): 329-340.Disponible en: http://www.sciencedirect.com/science/article/pii/S0147957107000537

  24. Mui Wang S, Devi Sekaran S. Evaluation of a commercial SD dengue virus NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection. J Cli Microbiol. 2010[citado 5 ago 2015]; 48(8):2793-2797. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916626/

  25. Correa Martínez L, Cabrera Morales C, Martínez Licor M, Martínez Núñez M. Consideraciones clínicas y terapéuticas sobre el dengue. CCM .2016 [citado 25 abr 2016]; 20(1): 80-97. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812016000100008&lng=es

  26. Basu A, Chaturvedi UC. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol. 2008 [citado 3 dic 2015]; 53(3):287-299. Disponible en: http://femsim.oxfordjournals.org/content/femsim/53/3/287.full.pdf

  27. Paranavitane SA, Gomes L, Kamaladasa A, Adikari TN, Wickramasinghe N, Jeewandara C, et al. Dengue NS1 antigen as a marker of severe clinical disease. BMC Infect Dis. 2014[citado 16 dic 2015]; 14:570 Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222370/

  28. Pal S, Dauner AL, Mitra I, Forshey BM, Garcia P, Morrison AC, et al. Evaluation of Dengue NS1 antigen rapid tests and ELISA Kits Using Clinical Samples. PLoS One.2014 [citado 4 may 2016]; 9(11). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239072/

  29. García Menéndez G, Izquierdo Oliva A, Salinas Fernández EM, Pérez Díaz AB, Sierra Vázquez B, López Ramón D, et al. Posible relación entre mastocitos y plaquetas en la infección por dengue. Rev Cubana Med Trop .2014 [citado 25 mar 2015]; 66(1):152-157. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602014000100015&lng=es&nrm=iso&tlng=es

  30. Torrentes Carvalho A, Ferreira Marinho C, de Oliveira Pinto LM, Batista de Oliveira D, Vieira Damasco P, Venâncio Cunha R , et al. Regulation of T lymphocyte apoptotic markers is associated to cell activation during the acute phase of dengue. Immunobiology .2014 [citado 4 may 2015]; 219(5):329-340. Disponible en: http://www.sciencedirect.com/science/article/pii/S0171298513002040

  31. Sierra B, Pérez AB, García G, Aguirre E, Álvarez M, González D, et al. Role of CC chemokine receptor 1 and 2 of its ligands in human dengue infection. Three approaches under the Cuban situation. Microbes infect. 2014[citado 4 may 2016]; 16(1):40-50. Disponible en: http://www.sciencedirect.com/science/article/pii/S128645791300213X

  32. Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, Tannenbaum SR. Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHF. PLoS Negl Trop Dis. 2012[citado 26 jul 2015]; 6(11). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510095/

  33. Yacoub S, Wills B. Predicting outcome from dengue. BMC Med. 2014[citado 26 dic 2015]; 12:147.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154521/

  34. Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto HC, et al. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol. 2014[citado 25 mar 2015]; 193(4):1864-1872. Disponible en: http://www.jimmunol.org/content/193/4/1864

  35. Becerra A, Warke RV, Bosch N, Rothman AL, Bosch I. Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine. 2008; [citado 25 mar 2015]; 41(2):114-120. Disponible en: http://www.sciencedirect.com/science/article/pii/S1043466607004747

  36. King N, Thomas SR. Molecules in focus: Indoleamine 2, 3-dioxygenase. Int J Biochem Cell Biol. 2007 [citado 26 mar 2015]; 39(12):2167-2172. Disponible en: http://www.sciencedirect.com/science/article/pii/S1357272507000271

  37. Soundravally R, Agieshkumar B, Daisy M, Sherin J, Cleetus CC. Ferritin levels predict severe dengue. Infection. 2015 [citado 24 mar 2015]; 43(1):13-19.Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25354733

  38. Punyadee N, Mairiang D, Thiemmeca S, Komoltri C, Pan-Ngum W, Chomanee N, et al. Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection. J Virol. 2015 [citado 28 ene 2015]; 89(3):1587-1607. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300736/

  39. Brasier AR, García J, Wiktorowicz JE, Spratt HM, Comach G, Ju H, et al. Discovery Proteomics and Nonparametric Modeling Pipeline in the Development of a Candidate Biomarker Panel for Dengue Hemorrhagic Fever. Clin Transl Sci. 2012 [citado 26 mar 2015]; 5(1):8-20. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1752-8062.2011.00377.x/full

  40. Ju H, Brasier A. Variable selection methods for developing a biomarker panel for prediction of dengue hemorrhagic fever. BCM Res Note. 2013[citado 12 mar 2015]; 6:365. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846812/

  41. Brasier A, Ju H, Garcia J, Spratt H, Victor SS, Forshey B, et al. A Three-Component Biomarker Panel for Prediction of Dengue Hemorrhagic Fever. Am J Trop Med Hyg. 2012 [citado 25 mar 2015]; 86(2):341-348. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269290/




2020     |     www.medigraphic.com